GlassScriptPhysician profile
Hannah Lancaster
NPI 1811598600
$8,628.72
in general payments reported to CMS, 2019-2025
49 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 93% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,191 · 2022: $1,839 · 2023: $1,748 · 2024: $1,326 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,598.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,692.98 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $1,360.61 | 2021 | |
| Novo Nordisk INC | $1,079.19 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $923.91 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $356.44 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Antares Pharma, INC. | $321.97 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Corcept Therapeutics | $292.61 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $270.77 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $212.80 | 2022-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $183.45 | 2022 | |
| Sanofi-Aventis U.S. LLC | $176.63 | 2021-2025 | |
| Noven Therapeutics, LLC | $164.07 | 2024-2025 | Xelstrym |
| Pfizer INC. | $134.13 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.97 | 2022 | |
| Inspire Medical Systems, INC. | $118.52 | 2024 | Inspire |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Lancaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.